Masimo | MASI - Sales Revenues

Stock Price
176.20
Daily Change
0.23 0.13%
Monthly
0.50%
Yearly
2.00%
Q1 Forecast
170.19

Masimo reported $412.5M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.05B 54.3M Dec/2025
AngioDynamics USD 72M 841K Feb/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
General Electric Aerospace USD 11.87B 560M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 697.26M 15.36M Sep/2025
ResMed USD 1.4B 100M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025